Heron Therapeutics Inc. 披露的SEC文件显示,该许可协议初始期限设定为十年,到期后将自动续展,每次续期时长为两年。
Heron Therapeutics Inc. 披露的SEC文件显示,该许可协议初始期限设定为十年,到期后将自动续展,每次续期时长为两年。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.